AU2001267899A1 - Pharmaceutical compositions for controlling intraocular pressure - Google Patents

Pharmaceutical compositions for controlling intraocular pressure

Info

Publication number
AU2001267899A1
AU2001267899A1 AU2001267899A AU6789901A AU2001267899A1 AU 2001267899 A1 AU2001267899 A1 AU 2001267899A1 AU 2001267899 A AU2001267899 A AU 2001267899A AU 6789901 A AU6789901 A AU 6789901A AU 2001267899 A1 AU2001267899 A1 AU 2001267899A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
intraocular pressure
controlling intraocular
controlling
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267899A
Inventor
Yoichi Iimura
Akira Kato
Takashi Kosasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of AU2001267899A1 publication Critical patent/AU2001267899A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
AU2001267899A 2000-07-03 2001-07-02 Pharmaceutical compositions for controlling intraocular pressure Abandoned AU2001267899A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000200899 2000-07-03
JP2000-200899 2000-07-03
JP2000230319 2000-07-31
JP2000-230319 2000-07-31
PCT/JP2001/005714 WO2002002526A1 (en) 2000-07-03 2001-07-02 Pharmaceutical compositions for controlling intraocular pressure

Publications (1)

Publication Number Publication Date
AU2001267899A1 true AU2001267899A1 (en) 2002-01-14

Family

ID=26595256

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267899A Abandoned AU2001267899A1 (en) 2000-07-03 2001-07-02 Pharmaceutical compositions for controlling intraocular pressure

Country Status (2)

Country Link
AU (1) AU2001267899A1 (en)
WO (1) WO2002002526A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091218B1 (en) 1999-09-01 2006-08-15 Eisai Co., Ltd. 4-substituted piperidine compound
EP1300395B1 (en) * 2000-06-21 2009-09-02 Eisai R&D Management Co., Ltd. 4-substituted piperidine compound
JP2005154320A (en) * 2003-11-25 2005-06-16 Ss Pharmaceut Co Ltd Therapeutic agent for eye disease
WO2005076749A2 (en) * 2004-02-11 2005-08-25 Jubilant Organosys Limited A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine
US8346956B2 (en) 2004-10-29 2013-01-01 Akamai Technologies, Inc. Dynamic image delivery system
KR101714575B1 (en) 2015-10-15 2017-03-09 국방과학연구소 Pyridinium Oxime Derivatives or Pharmaceutical Acceptable Salts thereof, and Pharmaceutical Compositions Comprising the Same as an Active Ingredient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
WO1998056379A1 (en) * 1997-06-11 1998-12-17 Alcon Laboratories, Inc. Compositions and methods for treating glaucoma
WO1998056380A1 (en) * 1997-06-11 1998-12-17 Alcon Laboratories, Inc. Method to reverse mydriasis
KR100694682B1 (en) * 1999-03-03 2007-03-13 에자이 알앤드디 매니지먼트 가부시키가이샤 Fluorides of 4-substituted piperidine derivatives
US7091218B1 (en) * 1999-09-01 2006-08-15 Eisai Co., Ltd. 4-substituted piperidine compound

Also Published As

Publication number Publication date
WO2002002526A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002300377A1 (en) Compositions for controlled release
AU2002313236A1 (en) Medicinal compositions
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2001287967A1 (en) Connection for dental prostheses
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2002224525A1 (en) Compositions for regulating desire for smoking
AU2001290239A1 (en) Medicinal composition
AU2001273919A1 (en) Pharmaceutical compositions
AU2001267899A1 (en) Pharmaceutical compositions for controlling intraocular pressure
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU2001240557A1 (en) Implant for cranioplastics
AU4085201A (en) Pharmaceutical composition
AU2002354460A1 (en) Medicinal composition
AU2001292578A1 (en) Pharmaceutical compounds
AU2001278705A1 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions
AU4707900A (en) Methods for controlling intraocular pressure